Here’s what you need to know about the study, Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season.| Association of Immunization Managers
AIM invites participation in its Immunization Program and Birthing Institution Community of Practice (CoP) to Optimize Administration of Birth Dose Immunizations.| Association of Immunization Managers
On July 9, 2025, the FDA released its decision to approve the supplemental Biologics License Application (BLA) for SPIKEVAX, but only for certain ages at high risk.| Association of Immunization Managers
Likely you’ve heard some back-and-forth recently about the use of aluminum as an adjuvant in vaccines. Here’s what you need to know from both sides of the argument.| Association of Immunization Managers
A look at a recent study, Long-term Dynamics of Measles Virus–Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age.| Association of Immunization Managers
A study found that 15.4% of children ages 0 to 35 months received at least one invalid vaccine dose.| Association of Immunization Managers
A study found that combining provider education with other interventions has the potential to significantly improve HPV vaccine initiation rates.| Association of Immunization Managers
